Skip to main content

Table 3 Preoperative and Postoperative PHQ-9 and VAS scores of two groups

From: Effects of a single subanesthetic dose of esketamine on postoperative subthreshold depressive symptoms in patients undergoing unilateral modified radical mastectomy: a randomised, controlled, double-blind trial

 

Control group

Esketamine group

P-value

PHQ-9 score

 Before

3.28 ± 3.15

3.22 ± 3.44

0.718

 POD 1

4.03 ± 3.84

2.19 ± 2.75

0.047

 POD 3

3.25 ± 2.71

2.56 ± 3.27

0.143

 POD 7

3.16 ± 2.94

1.91 ± 2.26

0.100

 POD 30

2.44 ± 2.94

1.72 ± 2.05

0.482

VAS score

 Before

0.78 ± 1.58

0.69 ± 1.47

1.000

 POD 1

1.22 ± 1.70

1.28 ± 1.97

0.996

 POD 3

0.78 ± 1.13

0.75 ± 1.11

0.951

 POD 7

0.75 ± 1.32

0.69 ± 1.28

0.994

 POD 30

0.34 ± 0.75

0.34 ± 0.79

1.000

  1. PHQ-9 Patient Health Questionnaire-9. POD postoperative day. VAS visual analogue scale